Guest guest Posted August 2, 2006 Report Share Posted August 2, 2006 Xoma Stops Work on Experimental Hepatitis Drug East Bay Business Times - Jul. 31, 2006 Xoma Ltd. said late Friday it stopped work on an experimental hepatitis B drug after the company that developed it backed out of a research deal. Berkeley-based Xoma (NASDAQ: XOMA) was working with Cubist Pharmaceuticals Inc. (NASDAQ: CBST) on the drug HepeX-B, but said Cubist stopped its investment in the project because of stringent Food and Drug Administration requirements. Xoma and Cubist made a deal in September 2005 in which Xoma worked to find new ways of manufacturing HepeX-B. Xoma has notified Cubist that it will terminate their contract, although the two companies are discussing other options for the drug. HepeX-B has been granted Orphan Drug Status by both European and American regulators. http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=1024652 & contentty\ pe=sentryarticle & channelID=31 _________________________________________________________________ On the road to retirement? Check out MSN Life Events for advice on how to get there! http://lifeevents.msn.com/category.aspx?cid=Retirement Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 2, 2006 Report Share Posted August 2, 2006 Xoma Stops Work on Experimental Hepatitis Drug East Bay Business Times - Jul. 31, 2006 Xoma Ltd. said late Friday it stopped work on an experimental hepatitis B drug after the company that developed it backed out of a research deal. Berkeley-based Xoma (NASDAQ: XOMA) was working with Cubist Pharmaceuticals Inc. (NASDAQ: CBST) on the drug HepeX-B, but said Cubist stopped its investment in the project because of stringent Food and Drug Administration requirements. Xoma and Cubist made a deal in September 2005 in which Xoma worked to find new ways of manufacturing HepeX-B. Xoma has notified Cubist that it will terminate their contract, although the two companies are discussing other options for the drug. HepeX-B has been granted Orphan Drug Status by both European and American regulators. http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=1024652 & contentty\ pe=sentryarticle & channelID=31 _________________________________________________________________ On the road to retirement? Check out MSN Life Events for advice on how to get there! http://lifeevents.msn.com/category.aspx?cid=Retirement Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.